OMass Therapeutics
Pre-clinicalDiscovers and develops small molecule drugs targeting membrane protein complexes for immunological and neurological diseases.
Founded
2016
Focus
Small MoleculesImmunologyNeuroscience
About
Discovers and develops small molecule drugs targeting membrane protein complexes for immunological and neurological diseases.
Funding History
3Total raised: $175M
Series B$100MSynconaNov 15, 2023
Series A$60MSynconaJun 15, 2021
Seed$15MOxford Sciences InnovationJun 15, 2018
Company Info
TypePrivate
Founded2016
LocationOxford, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile